New Delhi: India’s drug regulator has granted emergency use authorisation for Biological E’s COVID-19 vaccine Corbevax for those aged five to 12 years and Bharat Biotech’s Covaxin for children in the age group of six to 12 years, Union Health Minister Mansukh Mandaviya said on Tuesday.
...DCGI nod to emergency use of Corbevax for 5-12, Covaxin for 6-12 age group
The Drugs Controller General of India has also granted emergency use authorisation to Cadila for its ZyCoV-D for an additional dose of 3mg with a two-jab inoculation schedule 28 days apart for those aged above 12 years.